Unknown PHASE4 INTERVENTIONAL 2-arm NCT01171703

Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) (DCLI-I)

Optimized Strategy for Diabetic Patients With Critical Limb Ischemia: A Multi-center, Randomized Controlled Trial and Registration Study(Part I)

Sponsor: Beijing Tongren Hospital

Conditions Diabetes Vascular Diseases

Interventions femoral-popliteal bypass stent

Updated 8 times since 2017 Last updated: Dec 20, 2012 Started: Nov 30, 2010 Primary completion: Jul 31, 2013 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01171703, this PHASE4 trial focuses on Diabetes and Vascular Diseases and remains ongoing. Sponsored by Beijing Tongren Hospital, it has been updated 8 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Aug 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jul 2018 — Aug 2018 [monthly]

Unknown Status PHASE4

▶ Show 3 earlier versions

Jun 2018 — Jul 2018 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Enrolling By Invitation → Unknown Status
Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE4

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Tongren Hospital
Peking Union Medical College Hospital
Xuanwu Hospital, Beijing

Data source: Peking Union Medical College Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China